Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

0.7300
+0.00070.10%
Post-market: 0.73000.00000.00%19:51 EDT
Volume:121.62K
Turnover:92.06K
Market Cap:34.17M
PE:-1.04
High:0.8000
Open:0.7293
Low:0.7201
Close:0.7293
52wk High:2.93
52wk Low:0.7201
Shares:46.80M
Float Shares:19.94M
Volume Ratio:0.74
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7050
EPS(LYR):-0.7584
ROE:-142.60%
ROA:-68.49%
PB:0.78
PE(LYR):-0.96

Loading ...

InspireMD grants 91,161 restricted shares to six new employees under inducement plan

Reuters
·
4 hours ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
4 hours ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
4 hours ago

InspireMD says FDA reviews PMA supplement for CGuard Prime 80 cm stent in TCAR use

Reuters
·
Jun 11

InspireMD reports zero major adverse events at 30 days in CGUARDIANS II TCAR study of CGuard Prime 80 cm stent

Reuters
·
Jun 11

InspireMD - No Deaths, Strokes, or Myocardial Infarctions Reported Within 30 Days in Cguardians Ii

THOMSON REUTERS
·
Jun 11

InspireMD - Cguardians Ii Trial Achieves 100% Acute Device Success Rate

THOMSON REUTERS
·
Jun 11

InspireMD Inc: Anticipates Potential Approval of Cguard Prime 80 Cm Stent Implant in Second Half of This Year

THOMSON REUTERS
·
Jun 11

InspireMD Announces 30-Day Results From the Cguardians Ii Clinical Trial of the Cguard Prime 80 Cm Implant for Use in Tcar Procedures

THOMSON REUTERS
·
Jun 11

InspireMD Announces First Patient Enrolled in the Cguardians Iii Pivotal Study of the Switchguard Neuro Protection System for Use in Tcar Procedures

THOMSON REUTERS
·
Jun 08

InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures

GlobeNewswire
·
Jun 08

InspireMD Shareholders Approve Stock Increase and Board Slate

TIPRANKS
·
Jun 04

InspireMD shareholders approve increase in authorized common shares to 250 million

Reuters
·
Jun 04

InspireMD director Paul Stuka acquires 20,000 common shares valued at $17,500

Reuters
·
May 30

InspireMD chair Paul Stuka to retire, won’t seek board reelection in 2027

Reuters
·
May 23

Top InspireMD Executive Makes Notable Move With Latest Stock Sale

TIPRANKS
·
May 22

InspireMD director Paul Stuka buys USD 17,325 common shares

Reuters
·
May 16

Top Executive Makes Bold Move With Fresh InspireMD Stock Purchase

TIPRANKS
·
May 14

InspireMD CEO Marvin Slosman acquires 21,000 shares valued at $25,200

Reuters
·
May 14

InspireMD director Paul Stuka buys common shares worth $87,125.56

Reuters
·
May 13